Patent · US Active

Substituted pyrimidine kinase inhibitors

US8013153B2 · kind B2 · utility

7Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2007
Grant dateSep 6, 2011
Priority date
Expiry dateMay 21, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is directed to substituted pyrimidine compounds of formula (I):and forms thereof, their synthesis and use for treating a chronic or acute protein kinase mediated disease, disorder or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.